
Pubmed-entry ::= {
  pmid 29428541,
  medent {
    em std {
      year 2018,
      month 2,
      day 12,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "Jelly containing composite based on alpha-glucosyl stevia and
 polyvinylpyrrolidone: Improved dissolution property of curcumin."
      },
      authors {
        names std {
          {
            name ml "Uchiyama H",
            affil str "Osaka University of Pharmaceutical Sciences, 4-20-1
 Nasahara, Takatsuki, Osaka 569-1094, Japan."
          },
          {
            name ml "Nogami S",
            affil str "Osaka University of Pharmaceutical Sciences, 4-20-1
 Nasahara, Takatsuki, Osaka 569-1094, Japan."
          },
          {
            name ml "Katayama K",
            affil str "Osaka University of Pharmaceutical Sciences, 4-20-1
 Nasahara, Takatsuki, Osaka 569-1094, Japan."
          },
          {
            name ml "Hayashi K",
            affil str "Osaka University of Pharmaceutical Sciences, 4-20-1
 Nasahara, Takatsuki, Osaka 569-1094, Japan."
          },
          {
            name ml "Kadota K",
            affil str "Osaka University of Pharmaceutical Sciences, 4-20-1
 Nasahara, Takatsuki, Osaka 569-1094, Japan."
          },
          {
            name ml "Tozuka Y",
            affil str "Osaka University of Pharmaceutical Sciences, 4-20-1
 Nasahara, Takatsuki, Osaka 569-1094, Japan. Electronic address:
 ytozuka@gly.oups.ac.jp."
          }
        }
      },
      from journal {
        title {
          iso-jta "Eur J Pharm Sci",
          ml-jta "Eur J Pharm Sci",
          issn "1879-0720",
          name "European journal of pharmaceutical sciences : official journal
 of the European Federation for Pharmaceutical Sciences"
        },
        imp {
          date std {
            year 2018,
            month 5,
            day 30
          },
          volume "117",
          pages "48-54",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus received,
              date std {
                year 2017,
                month 11,
                day 29
              }
            },
            {
              pubstatus revised,
              date std {
                year 2018,
                month 1,
                day 23
              }
            },
            {
              pubstatus accepted,
              date std {
                year 2018,
                month 2,
                day 7
              }
            },
            {
              pubstatus pubmed,
              date std {
                year 2018,
                month 2,
                day 13,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2018,
                month 10,
                day 3,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus other,
              date std {
                year 2018,
                month 2,
                day 12,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 29428541,
        pii "S0928-0987(18)30073-3",
        doi "10.1016/j.ejps.2018.02.011",
        other {
          db "ELocationID pii",
          tag str "S0928-0987(18)30073-3"
        },
        other {
          db "ELocationID doi",
          tag str "10.1016/j.ejps.2018.02.011"
        }
      }
    },
    abstract "Curcumin (CUR) solutions prepared with alpha-glucosyl stevia
 (Stevia-G) and polyvinylpyrrolidone K-30 (PVP) by evaporation method showed
 11,000-fold higher solubility compared to CUR alone. Tri-component
 formulations of CUR/Stevia-G/PVP in aqueous solution showed improved CUR
 stability for precipitation-triggering conditions of CUR, such as aqueous
 dilution and temperature changes. Fluorescence study with CUR and pyrene
 indicated that Stevia-G/PVP mixed solutions produce a more hydrophilic
 microenvironment around their molecules with increasing PVP concentration
 compared to Stevia-G solution alone. These results suggested the composite
 formation associated with the adsorption of the aggregated structure of
 Stevia-G onto PVP molecules. Jelly formulations were prepared with
 kappa-carrageenan, and jelly formulations containing nanocomposites formed by
 CUR/Stevia-G/PVP obviously enhanced the dissolution properties of CUR
 compared to CUR powder. This result indicated that the composite formed by
 CUR/Stevia-G/PVP could be maintained even after the preparation of jelly and
 release into a dissolution media. Production of jelly formulations using
 Stevia-G and PVP are a promising way to improve the dissolution properties of
 CUR.",
    mesh {
      {
        term "Carrageenan",
        qual {
          {
            subh "chemistry"
          }
        }
      },
      {
        term "Curcumin",
        qual {
          {
            mp TRUE,
            subh "chemistry"
          }
        }
      },
      {
        term "Drug Liberation"
      },
      {
        term "Drug Stability"
      },
      {
        term "Nanocomposites",
        qual {
          {
            subh "chemistry"
          }
        }
      },
      {
        term "Povidone",
        qual {
          {
            mp TRUE,
            subh "chemistry"
          }
        }
      },
      {
        term "Solubility"
      },
      {
        term "Stevia",
        qual {
          {
            mp TRUE,
            subh "chemistry"
          }
        }
      }
    },
    substance {
      {
        type cas,
        cit "9000-07-1",
        name "Carrageenan"
      },
      {
        type cas,
        cit "FZ989GH94E",
        name "Povidone"
      },
      {
        type cas,
        cit "IT942ZTH98",
        name "Curcumin"
      }
    },
    pmid 29428541,
    pub-type {
      "Journal Article"
    },
    status medline
  }
}


